Atlas Trials

A Biological Prospective Study in Patients With Metastatic Pancreatic NETs Treated With Everolimus

Clinical trial NCT02305810 · COMPLETED

Trial details

NCT number
NCT02305810
Sponsor
European Institute of Oncology
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Neuroendocrine Tumour Metastatic
Start date
2013-09-01
Primary completion
2017-01-12
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.